InvestorsHub Logo
Followers 30
Posts 5070
Boards Moderated 0
Alias Born 01/07/2020

Re: None

Friday, 10/30/2020 8:35:01 AM

Friday, October 30, 2020 8:35:01 AM

Post# of 426566

Science has learned that both FDA’s decision and the EU deal came about under unusual circumstances that gave the company important advantages.


https://www.sciencemag.org/news/2020/10/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug

“This is a very, very bad look for the FDA, and the dealings between Gilead and EU make it another layer of badness,” says Eric Topol, a cardiologist at the Scripps Research Translational Institute who objected to remdesivir’s FDA approval.


Not fair that the article tries to tie President into this (the picture at the top). He did from the start endorse Dr. Zelenco's HCQ treatment - and was tormented for it. Apart from that a great article that reveals what has been going on - behind the scenes in the pandemic.

Jasbg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News